ArticleEMBO molecular medicine2026

FAP adipogenesis drives early spinal muscle loss in dysferlinopathy and reveals a therapeutic target.

Young Jae Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.